C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 265/32 (2006.01) A61K 31/4168 (2006.01) A61K 31/5375 (2006.01) A61K 31/5377 (2006.01) C07D 233/46 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2517391
The invention relates to novel compounds of formula (I), wherein R1, R2, R3, X and Y have the meanings as cited in Patent Claim 1. The compounds are inhibitors of coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
L'invention concerne de nouveaux composés représentés par la formule (I) dans laquelle R?1¿, R?2¿, R?3¿, X et Y ont la signification donnée dans la revendication (1). Ces composés sont des inhibiteurs du facteur de coagulation Xa et peuvent servir à la prophylaxie et/ou à la thérapie de maladies thrombo-emboliques et au traitement de tumeurs.
Cezanne Bertram
Dorsch Dieter
Gleitz Johannes
Mederski Werner
Tsaklakidis Christos
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Ethynyl derivatives serving as factor xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ethynyl derivatives serving as factor xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ethynyl derivatives serving as factor xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1976572